NO20074874L - Amorf lerkanidipinhydroklorid - Google Patents

Amorf lerkanidipinhydroklorid

Info

Publication number
NO20074874L
NO20074874L NO20074874A NO20074874A NO20074874L NO 20074874 L NO20074874 L NO 20074874L NO 20074874 A NO20074874 A NO 20074874A NO 20074874 A NO20074874 A NO 20074874A NO 20074874 L NO20074874 L NO 20074874L
Authority
NO
Norway
Prior art keywords
amorphous lercanidipine
lercanidipine hydrochloride
approx
substantially pure
pure amorphous
Prior art date
Application number
NO20074874A
Other languages
English (en)
Other versions
NO344559B1 (no
Inventor
Gianni Motta
Amedeo Leonardi
Fabio Berlati
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36585434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074874(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of NO20074874L publication Critical patent/NO20074874L/no
Publication of NO344559B1 publication Critical patent/NO344559B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen tilveiebringer et stort sett rent amorft lerkanidipinhydroklorid som har en renhet på minst 95 %, fortrinnsvis minst ca. 97 %, mer foretrukket minst ca. 99 % og enda mer foretrukket minst ca. 99,5 %. Oppfinnelsen tilveiebringer videre fremgangsmåte for fremstilling av stort sett rent amorft lerkanidipin og farmasøytiske sammensetninger inneholdende det stort sett rene amorfe lerkanidipinet.
NO20074874A 2005-02-25 2007-09-25 Amorf lerkanidipinhydroklorid NO344559B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65683605P 2005-02-25 2005-02-25
PCT/EP2006/001782 WO2006089787A1 (en) 2005-02-25 2006-02-24 Amorphous lercanidipine hydrochloride

Publications (2)

Publication Number Publication Date
NO20074874L true NO20074874L (no) 2007-11-26
NO344559B1 NO344559B1 (no) 2020-02-03

Family

ID=36585434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074874A NO344559B1 (no) 2005-02-25 2007-09-25 Amorf lerkanidipinhydroklorid

Country Status (32)

Country Link
US (1) US7820701B2 (no)
EP (1) EP1856051B1 (no)
JP (1) JP2008531515A (no)
KR (1) KR20070105979A (no)
CN (1) CN101124204A (no)
AR (1) AR052918A1 (no)
AU (1) AU2006218026B9 (no)
BR (1) BRPI0608138A2 (no)
CA (1) CA2598016A1 (no)
CY (1) CY1122429T1 (no)
DK (1) DK1856051T3 (no)
EA (1) EA014383B1 (no)
ES (1) ES2339213T3 (no)
HR (1) HRP20192302T1 (no)
HU (1) HUE046910T2 (no)
IL (1) IL184349A0 (no)
LT (1) LT1856051T (no)
ME (1) ME03659B (no)
MX (1) MX2007010093A (no)
MY (1) MY142129A (no)
NO (1) NO344559B1 (no)
NZ (1) NZ556667A (no)
PE (1) PE20061014A1 (no)
PL (1) PL1856051T3 (no)
PT (1) PT1856051T (no)
RS (1) RS59654B1 (no)
SI (1) SI1856051T1 (no)
TW (1) TW200640861A (no)
UA (1) UA90130C2 (no)
UY (1) UY29401A1 (no)
WO (1) WO2006089787A1 (no)
ZA (1) ZA200708127B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4709545B2 (ja) * 2002-07-26 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 修飾された低分子干渉ｒｎａ分子および使用方法
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
EP1940790B1 (en) 2005-09-16 2015-09-02 Glenmark Pharmaceuticals Limited Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
SI2046745T1 (sl) * 2006-08-04 2014-02-28 Recordati Ireland Limited Postopek za pripravo amorfnega lerkanidipin hidroklorida
WO2008068777A2 (en) * 2006-12-06 2008-06-12 Torrent Pharmaceuticals Limited Stable lercanidipine formulation
CN101868442A (zh) * 2007-03-05 2010-10-20 阿克塔维什集团Ptc公司 盐酸乐卡地平多晶型物和1,1,n-三甲基-n-(3,3-二苯基丙基)-2-氨基乙酰醋酸乙酯的改进制法
AU2010247766B2 (en) * 2009-05-12 2015-05-21 Corcept Therapeutics, Inc. Solid forms and process for preparing
DE102010005124A1 (de) * 2010-01-19 2012-03-01 Stada Arzneimittel Ag Feste pharmazeutische Zusammensetzung umfassend Lercanidipin
EP2444394A1 (en) 2010-10-21 2012-04-25 Alembic Pharmaceuticals Limited Process for the preparation of amorphous form of lercanidipine HCI
CN102531999B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 无定形盐酸乐卡地平及其制备方法
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102600146B (zh) * 2012-04-11 2014-10-08 兆科药业（合肥）有限公司 一种盐酸乐卡地平和氯沙坦钾复方制剂及其制备方法
US9951009B2 (en) * 2013-08-29 2018-04-24 Cadila Healthcare Limited Polymorphic form of pyrrole derivative and intermediate thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
US5767136A (en) * 1995-05-12 1998-06-16 Recordati, S.A. Chemical And Pharmaceutical Company 1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial walls
US5696139A (en) * 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
IT1274480B (it) 1995-05-12 1997-07-17 Recordati Chem Pharm Procedimento migliorato per la preparazione della lercanidipina cloridrato
US6852737B2 (en) * 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
ITMI20011726A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
ITMI20011727A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi
US20030069285A1 (en) * 2001-08-06 2003-04-10 Recordati Ireland Limited Novel solvate and crystalline forms of lercanidipine hydrochloride
US20030180355A1 (en) * 2001-10-16 2003-09-25 Amedeo Leonardi Combination therapy for hypertension
JP4749660B2 (ja) * 2002-10-16 2011-08-17 武田薬品工業株式会社 安定な固形製剤
US20040147566A1 (en) * 2002-10-16 2004-07-29 Amedeo Leonardi Lisinopril/lercanidipine combination therapy
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
KR100651212B1 (ko) 2004-10-27 2006-12-01 제일약품주식회사 무정형 레르카니디핀의 제조방법
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
EP1940790B1 (en) 2005-09-16 2015-09-02 Glenmark Pharmaceuticals Limited Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
WO2007054969A2 (en) 2005-09-21 2007-05-18 Torrent Pharmaceuticals Limited Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride
SI2046745T1 (sl) 2006-08-04 2014-02-28 Recordati Ireland Limited Postopek za pripravo amorfnega lerkanidipin hidroklorida

Also Published As

Publication number Publication date
US20060211742A1 (en) 2006-09-21
MX2007010093A (es) 2007-10-12
RS59654B1 (sr) 2020-01-31
CY1122429T1 (el) 2021-01-27
EA014383B1 (ru) 2010-10-29
IL184349A0 (en) 2007-10-31
ES2339213T3 (es) 2020-05-28
PL1856051T3 (pl) 2020-05-18
WO2006089787A1 (en) 2006-08-31
NO344559B1 (no) 2020-02-03
MY142129A (en) 2010-09-30
KR20070105979A (ko) 2007-10-31
HRP20192302T1 (hr) 2020-03-06
CA2598016A1 (en) 2006-08-31
UA90130C2 (ru) 2010-04-12
PE20061014A1 (es) 2006-10-03
US7820701B2 (en) 2010-10-26
SI1856051T1 (sl) 2020-02-28
CN101124204A (zh) 2008-02-13
ME03659B (me) 2021-01-20
BRPI0608138A2 (pt) 2009-11-17
ES2339213T1 (es) 2010-05-18
EA200701687A1 (ru) 2008-02-28
JP2008531515A (ja) 2008-08-14
DK1856051T3 (da) 2020-01-02
AR052918A1 (es) 2007-04-11
TW200640861A (en) 2006-12-01
PT1856051T (pt) 2020-01-07
LT1856051T (lt) 2020-01-10
NZ556667A (en) 2009-10-30
EP1856051B1 (en) 2019-11-13
AU2006218026B9 (en) 2011-10-27
AU2006218026B2 (en) 2009-04-02
UY29401A1 (es) 2006-06-30
ZA200708127B (en) 2008-11-26
AU2006218026A1 (en) 2006-08-31
EP1856051A1 (en) 2007-11-21
HUE046910T2 (hu) 2020-04-28

Similar Documents

Publication Publication Date Title
CY1122429T1 (el) Αμορφη υδροχλωρικη λερκανιδιπινη
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
AP1830A (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same.
NO20092412L (no) Hydantoinderivater anvendes som MMP-inhibitorer
DK1707562T3 (da) Krystallinsk v-form af ivabradin-hydrochlorid, fremgangsmåde til fremstilling heraf og famaceutiske sammensætninger, som indeholder denne
NO20092611L (no) Krystallinsk faststoff Rasagilin base
CY1117051T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν κρυσταλλικη μορφη (i) της υδροχλωριουχου λερκανιδιπινης
WO2004096128A3 (en) Hiv integrase inhibitors
NO20072494L (no) Fast farmasoytisk forbindelse som omfatter donepezil-hydroklorid
NO20073572L (no) Nye forbindelser
NO20071372L (no) Nye polymorfer av azabisykloheksan
UA89394C2 (uk) Композиція оланзапіну або донепезилу, що розпадається при пероральному прийомі
NO20073571L (no) Nye hydantoinderivater som metallproteinaseinhibitorer
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
NO20052683D0 (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20071012L (no) Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
TW200508195A (en) 3-aminopyrrolidines as inhibitors of monoamine uptake
NO20064344L (no) Caspaseinhibitorer og anvendelser derav
NO20074873L (no) Lerkanidipinfri base
NO20074259L (no) Fremgangsmate for fremstilling av substituerte benzoksazolforbindelser
WO2005007642A3 (en) Novel azaheterocyclic amides useful for treating pain
GEP20094603B (en) NEW ASSOCIATION OF A SINUS CURRENT if INHIBITOR AND A CALCIC INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
NO20083521L (no) Rimonabantmonohydrat, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende samme
NO20070186L (no) Sammensetninger inneholdende nicorandil, fremstillingsfremgangsmate og anvendelse av sammensetningen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees